Definium Therapeutics, Inc. (DFTX) — Working Capital to Net Assets Ratio
Definium Therapeutics, Inc. (DFTX) has a Working Capital to Net Assets ratio of 101.8% as of June 2026. Working capital of $934.90 Million (current assets of $1.09 Billion minus current liabilities of $157.20 Million) is measured against net assets of $918.68 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See DFTX defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Definium Therapeutics, Inc. Working Capital to Net Assets (2015–2025)
This chart shows how Definium Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 101.8%, reflecting working capital of $934.90 Million against net assets of $918.68 Million USD. For the complete balance sheet picture, see balance sheet size of Definium Therapeutics, Inc..
Annual Working Capital to Net Assets for Definium Therapeutics, Inc. (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Definium Therapeutics, Inc. from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check DFTX asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 106.1% | $352.62 Million | $332.33 Million | $419.32 Million | $66.70 Million | ▲ +5.6 pp |
| 2024 | 100.5% | $242.77 Million | $241.45 Million | $281.62 Million | $38.85 Million | ▲ +8.9 pp |
| 2023 | 91.7% | $71.63 Million | $78.13 Million | $103.87 Million | $32.25 Million | ▲ +6.7 pp |
| 2022 | 84.9% | $128.16 Million | $150.92 Million | $146.06 Million | $17.89 Million | ▲ +1.3 pp |
| 2021 | 83.6% | $126.81 Million | $151.66 Million | $137.22 Million | $10.41 Million | ▼ -19.9 pp |
| 2020 | 103.5% | $78.51 Million | $75.87 Million | $81.52 Million | $3.01 Million | ▲ +3.5 pp |
| 2019 | 100.0% | $2.74 Million | $2.74 Million | $2.94 Million | $198.96K | ▲ +94.6 pp |
| 2018 | 5.4% | $190.40K | $3.52 Million | $198.63K | $8.23K | ▼ -37.4 pp |
| 2017 | 42.9% | $1.69 Million | $3.95 Million | $1.77 Million | $80.44K | ▼ -4.9 pp |
| 2016 | 47.7% | $60.72K | $127.28K | $136.19K | $75.47K | ▼ -15.3 pp |
| 2015 | 63.0% | $178.92K | $284.17K | $186.40K | $7.49K | — |